Clinical Trials Directory

Trials / Completed

CompletedNCT05660694

Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis

Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis: A Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Altamash Institute of Dental Medicine · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

To compare the efficacy of Triamcinolone with Pentoxifylline and Vitamin E in patients with stage two and three oral submucous fibrosis.

Detailed description

To compare the efficacy of Triamcinolone with Pentoxifylline and Vitamin E in patients with stage two and three oral submucous fibrosis. It was a randomized control clinical trial to compare efficacy of injection steroids versus pentoxifylline and vitamin E in the treatment of stage 2 and 3 OSF patient. Total 40 patients who presented with signs and symptoms of OSF were enrolled in our study that was evaluated over the period of (January 2020 to September 2021). Parameters taken in the study were age and mouth opening. Descriptive statistics and paired t-test were used for statistical analysis.

Conditions

Interventions

TypeNameDescription
DRUGTriamcinoloneComparison of Triamcinolone with Pentoxifylline and Vitamin- E Efficacy
DRUGPentoxifylline with Vitamin EComparison of Triamcinolone with Pentoxifylline and Vitamin- E Efficacy

Timeline

Start date
2020-01-01
Primary completion
2021-09-30
Completion
2021-09-30
First posted
2022-12-21
Last updated
2022-12-21

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05660694. Inclusion in this directory is not an endorsement.